Trial intelligence / Profile preview

VACC-IR: Pneumococcal and tetanus vaccine efficacy in hemodialysis vs renal transplant recipients on mycophenolic acid

2006-001806-94Phase 4Completed

Sponsor
Erasmus Hospital
Start
May 2006
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4 trial of Pneumo 23, pneumococcal 7-valent conjugate vaccine and diphtheria and tetanus toxoids in pneumococcal disease and Tetanus (2 arms), sponsored by Erasmus Hospital. Started May 2006; status: completed.

02

Drugs

Pneumo 23pneumococcal 7-valent conjugate vaccinediphtheria and tetanus toxoids
03

Conditions

pneumococcal diseaseTetanus

Beyond the preview

Go deeper on 2006-001806-94.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001806-94.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call